Banco de Sabadell’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $418K | Sell |
6,017
-2,872
| -32% | -$200K | 0.29% | 58 |
|
|
2025
Q1 | $652K | Buy |
8,889
+96
| +1% | +$7.04K | 0.5% | 55 |
|
|
2024
Q4 | $575K | Buy |
8,793
+1,209
| +16% | +$79.1K | 0.45% | 54 |
|
|
2024
Q3 | $593K | Buy |
7,584
+560
| +8% | +$43.8K | 0.44% | 56 |
|
|
2024
Q2 | $545K | Buy |
7,024
+219
| +3% | +$17K | 0.4% | 57 |
|
|
2024
Q1 | $458K | Sell |
6,805
-27
| -0.4% | -$1.82K | 0.34% | 60 |
|
|
2023
Q4 | $455K | Sell |
6,832
-18
| -0.3% | -$1.2K | 0.35% | 61 |
|
|
2023
Q3 | $460K | Buy |
6,850
+1,425
| +26% | +$95.7K | 0.4% | 60 |
|
|
2023
Q2 | $386K | Sell |
5,425
-21
| -0.4% | -$1.49K | 0.31% | 59 |
|
|
2023
Q1 | $381K | Sell |
5,446
-227
| -4% | -$15.9K | 0.32% | 59 |
|
|
2022
Q4 | $384K | Buy |
5,673
+112
| +2% | +$7.58K | 0.32% | 56 |
|
|
2022
Q3 | $304K | Sell |
5,561
-719
| -11% | -$39.3K | 0.25% | 61 |
|
|
2022
Q2 | $412K | Sell |
6,280
-167
| -3% | -$11K | 0.35% | 55 |
|
|
2022
Q1 | $425K | Buy |
6,447
+458
| +8% | +$30.2K | 0.25% | 65 |
|
|
2021
Q4 | $351K | Buy |
5,989
+552
| +10% | +$32.4K | 0.2% | 70 |
|
|
2021
Q3 | $328K | Sell |
5,437
-317
| -6% | -$19.1K | 0.22% | 75 |
|
|
2021
Q2 | $345K | Buy |
5,754
+380
| +7% | +$22.8K | 0.23% | 77 |
|
|
2021
Q1 | $266K | Sell |
5,374
-112
| -2% | -$5.54K | 0.03% | 201 |
|
|
2020
Q4 | $274K | Buy |
5,486
+367
| +7% | +$18.3K | 0.03% | 217 |
|
|
2020
Q3 | $279K | Buy |
5,119
+161
| +3% | +$8.78K | 0.03% | 251 |
|
|
2020
Q2 | $263K | Sell |
4,958
-602
| -11% | -$31.9K | 0.03% | 204 |
|
|
2020
Q1 | $250K | Buy |
5,560
+42
| +0.8% | +$1.89K | 0.04% | 219 |
|
|
2019
Q4 | $276K | Sell |
5,518
-185
| -3% | -$9.25K | 0.04% | 243 |
|
|
2019
Q3 | $256K | Sell |
5,703
-128
| -2% | -$5.75K | 0.04% | 248 |
|
|
2019
Q2 | $242K | Buy |
+5,831
| New | +$242K | 0.03% | 264 |
|